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CHAPTER ONE 
 
 INTRODUCTION 
 
Evolution and Genetic Regulation 
Even though different vertebrate species look quite diverse in their juvenile and 
adult forms, they all begin as a single fertilized egg and use similar developmental 
processes and genes to reach their mature state, which can be seen from comparisons of 
zebrafish to humans. There are early structural similarities among most vertebrate 
embryos during certain stages, including the presence of a head, pharyngeal arches, and a 
tail. Many of these early structures seem to be conserved among a variety of species, and 
it is the differential regulation of genetic networks that helps specific tissues of each 
organism differentiate according to evolutionarily and anatomically integrated patterns of 
gene expression (Gilbert, 2010). Particular genes are turned on and off at the appropriate 
place and time in development to regulate downstream targets and ensure the proper 
development of tissues for that particular organism. From the use of HOX genes in early 
developmental processes, to Netrins in axon guidance, many of these genetic networks 
are conserved throughout evolution (Manzanares et al., 2000, Rajasekharan et al., 2009). 
Even though organisms are constantly evolving in part due to the mutations that are 
randomly occurring in their genome, it makes sense that the amino acid sequence of the 
coding region of genes are highly conserved in order to maintain protein function 
(Bejerano et al., 2004; Pruitt K, 2009). It is more interesting that cis elements associated 
closely with genes tend to be functionally conserved through evolution, although relative 
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position and location in relation to the transcriptional start site appear to vary. This has 
led modern biology to focus on the evolution and function of these putative cis regulatory 
regions (Maston et al., 2006; ENCODE Project Consortium, 2012).  The conservation of 
these non-coding sequences over evolution suggests that they are not altered because they 
play an important role for the fitness of the organism, particularly in the regulation of the 
genome (Woolfe et al., 2005). Appropriate genetic regulation allows for normal cell 
growth, but if this process is interrupted it can have detrimental effects on the organism. 
In order to understand the components of this regulation it is necessary to identify the 
transcription factors essential for the transcriptional regulation. The presence of these 
regulatory proteins can accelerate or inhibit the rate of transcription by binding to DNA, 
which affects the amount of mRNA produced by the gene (Spitz and Furlong, 2012; 
Alberts, 2007). These transcription factors can bind upstream, downstream, near, or far 
from the transcriptional start site of a gene because it is the sequence of nucleotides that 
determine whether it is capable of binding (Palstra, 2012). The binding of these 
transcription factors emphasizes the necessity of organisms to conserve the function of 
non-coding portions of the genome based on their role in gene regulation. 
Cartilage and Collagens 
The requirement for abundant cartilage in a vast number of processes in vertebrate 
species suggests the genetic regulation of the genes critical for its formation is 
particularly important. Cartilage is a connective tissue evolved to be a support structure 
for organisms that also provides flexibility during movement. The elasticity of this tissue 
is essential in articular surfaces to support the movement of adjacent bones, in the 
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intervertebral discs to cushion the force and strain of the vertebrae, and the ear of mature 
animals (Fox et al., 2009; Roberts et al., 2006). Musculoskeletal issues, such as back pain 
caused by intervertebral disc degeneration and degradation of joint cartilage and 
osteoarthristis, can naturally develop as an individual ages due to wear and tear on the 
body. These conditions are becoming more prevalent and leading to a major healthcare 
concern in society (Le Maitre, 2007; Freemont, 2009; Goldring, 2012). 
Cartilage also has a significant role in the developing embryo because the 
endochondral bones that form many parts of the skeleton, like the lower jaw structure of 
gnathostomes, are initially composed of cartilage and will provide the framework for 
future bone formation (Kuratani, 2005; Kimmel et al., 1998). The differentiated cartilage 
cells, called chondrocytes, secrete extracellular matrix representative of cartilage. When 
the ossification process begins the chondrocytes undergo hypertrophy and a change in 
transcription factor regulation, which will begin the process of calcification of the 
chondrocytes and the mineralization of the matrix to form the skeleton (Mackie et al, 
2008; Vega et al., 2004). For example, it is the initial configuration of the cartilage that 
lays the framework for the lower jaw. This structure is neural crest derived and these cells 
migrate from the midbrain and hindbrain region into the pharyngeal arches to form the 
craniofacial cartilage, and eventually the bony lower jaw (Minoux and Rijli, 2010; Knight 
et al., 2006). This process shows that the tightly regulated spatiotemporal expression of 
transcription factors is not only important for the initial differentiation of chondrocytes, 
but also continues to play a role in the endochondral ossification process (Ding et al., 
2012; Yang and Karsenty, 2002; Gilbert, 2010). 
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Cartilage is mainly composed of an extracellular matrix of collagen and 
proteoglycans, which is secreted from proliferating chondrocytes (Gao et al., 2014). 
Collagen is an abundant fibrillar protein composed of a triple helix repeat, which can then 
link with other collagen molecules in the extracellular matrix (Exposito et al., 2010; 
Kadler, 1996). There are twenty-eight different collagen types that are present in a wide 
array of tissues including skin, eye, muscle, and cartilage; of these collagen types it is the 
type II collagen α1 (COL2A1) gene that is crucial in the cartilage, notochord, 
intervertebral disc, and vitreous humor of the eye (Cheah et al., 1991; Alberts et al., 
2007). Mutations to this gene can lead to congenital birth defects including 
Achondrogenesis, Stickler syndrome, and Spondyloperpheral dysplasia, and the 
detrimental results are characterized by spinal or skeletal deformities, hearing 
irregularities, or ocular abnormalities (Winterpacht et al., 1993; Brown et al., 1992; 
Kuivaniemi et al., 1991). 
Zebrafish have two orthologues of col2a1, referred to as col2a1a and col2a1b. 
Following the sequence analysis of the zebrafish homologues, our laboratory has shown 
overlapping expression patterns in the perichondrium of cartilage, but only col2a1a was 
expressed in the chondrocytes based on in situ hybridization (Dale and Topczewski, 
2011). Our laboratory focuses on col2a1a because of this expression in the chondrocytes 
and perichondrium of the craniofacial cartilage and the notochord. The goal of our 
research is to understand the transcriptional regulation of the zebrafish orthologue col2a1 
in order to elucidate the components required for col2a1a expression. Studying the 
fundamental aspects of col2a1a transcriptional regulation will provide us with a basic 
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understanding of how this evolutionary conserved and critical vertebrate gene functions. 
Understanding the transcription factors that determine its expression and the tissue 
specific activity of our identified enhancer element may lead to novel ways to initiate 
transcription in areas of deteriorating cartilage. By having a minimal regulatory element 
that can initiate transcription only in specific cell types will have implications for future 
research in the fields of synthetic biology and gene therapy. 
There are transcription factors that have already been shown to play an important 
role in chondrogenesis, including Sox9 (Yang and Karsenty, 2002; Ng et al., 1997; Yan 
et al., 2005). The mouse knockout of Sox9 results in a deficiency of cartilage and bone, 
to further emphasize the importance of the transcription factor in early development 
(Akiyama et al., 2002). Morpholino injections that target sox9a in zebrafish embryos also 
produce zebrafish with disrupted and/or lost craniofacial cartilage structures, similar to 
what is observed in mice (Yan et al., 2002). The injection of these targeted morpholinos 
was also performed by our laboratory to show the reduction of reporter protein levels 
specifically in cranial cartilage elements but not in the ear or notochord in our col2a1a 
reporter transgenic zebrafish line (Dale and Topczewski, 2011). While it is evident that 
Sox9a is an important transcription factor in the regulation of col2a1a, many other 
transcription factors certainly contribute to chondrogenesis. For example, Runx2 is a 
transcription factor known to be involved in osteoblast differentiation, but it can be 
inferred that this transcription factor has another role early in development because of its 
presence when chondrocytes begin to form (Otto et al., 1997; Kerney et al., 2007). In 
zebrafish, runx2b and runx3 are expressed at high levels as early as 34 hours post 
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fertilization which correlates to the development of the craniofacial cartilage; this 
spatiotemporal correlation implies the transcription factor could be important for 
regulation of col2a1a by binding to the regulatory element (Flores et al., 2006). These 
transcription factors are present at the correct time and place for cartilage formation, but 
it is most likely Runx2 that is responsible for this expression based on previous research 
(Ding et al., 2012; Flores et al., 2006). Similar to sox9a, the injection of antisense 
morpholinos for Runx proteins results in craniofacial deformities (Flores et al., 2006). 
Continued research of this transcription factor family will continue to enrich our 
knowledge of their different roles in the development of cartilage and the endochondral 
ossification process. The Sox and Runx transcription factors are also known to interact 
with the Ets family of transcription factors, a large class of DNA binding proteins. Fli1 is 
a member of the ERG subfamily of Ets family of transcription factors. Yeast two-hybid 
interactions have demonstrated its interactions with Sox proteins (Deramaudt et al., 
2001). Interestingly, Fli1 and Runx1 proteins have been confirmed to bind by 
immunoaffinity studies and transcriptional reporter assays (Huang et al., 2009). The 
interplay of these transcription factor proteins is particularly interesting because ERG is 
shown to have a role in cartilage differentiation and development (Dhordain et al., 1995; 
Iwamoto et al., 2001).  While these transcription factors are known to play a significant 
role in cartilage development, our research hopes to identify whether these proteins are 
binding to the critical regulatory element of col2a1a.   
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Zebrafish Model Organism 
Our laboratory is interested in studying the fundamental aspects of col2a1 
transcriptional regulation utilizing Danio rerio, commonly known as the zebrafish. 
Zebrafish are an excellent vertebrate model organism for our research because of their 
transparent embryo and reproductive capabilities (Westerfield, 2000). This transparency 
allows us to view development of the zebrafish without disrupting the embryo or mother, 
as well as visualize the presence of the fluorescent proteins using standard microscopy 
techniques. Their large clutch size and rapid development is also an advantage compared 
to other vertebrate model organisms. While these are beneficial for our research, it is the 
conservation of vertebrate signaling pathways that make zebrafish an ideal model 
organism for studying developmental pathways (Dooley and Zon, 2000). The ability to 
easily produce transgenic zebrafish will allow us to characterize the upstream regulatory 
element of collagen. 
Transcriptional Regulation of col2a1a 
A 182 bp regulatory element was identified in the first intron of the mouse Col2a1 
gene, and could drive expression of a reporter gene in chondrocytes (Zhou et al, 1995). 
Interestingly, the characterized mouse enhancer is quite weak and there have been 
suggestions in the field that there are other stronger enhancers elsewhere. Subsequently, 
our laboratory identified a 360 bp regulatory region in zebrafish as the region critical for 
cartilage, ear, and notochord expression of col2a1a, as determined by its ability to 
express enhanced green fluorescent protein (EGFP) at the proper time and place (Dale 
and Topczewski, 2011). The regulatory element important for this expression, referred to 
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as R2, was identified using comparative genomics of four distantly related teleost fish. 
Twelve kilobases (kb) of the zebrafish, medaka, fugu, and stickleback genome 
surrounding the transcriptional start site were compared, and four highly conserved 
sequences were discovered. When these conserved regions were placed upstream of a 
reporter gene to drive expression, only the R2 region drove EGFP expression in the 
appropriate tissues. The 360 bp regulatory region was approximately -1.7kb upstream of 
the transcriptional start site of col2a1a on chromosome 8, as indicated by the schematic 
in Figure 1. As previously published, the plasmid containing the R2 regulatory element 
driving expression of EGFP can recapitulate most of the endogenous expression of 
col2a1a, with the presence of this fluorescent protein in the cartilage, ear, and notochord. 
The goal of our research was to determine what region of R2 was responsible for 
initiating transcription, and by isolating this portion of the regulatory region for col2a1a 
we could begin to infer the mechanisms of its regulation. Deletion analysis of the R2 
regulatory region has been performed testing six 60 bp units designated as A through F, 
which allowed us to identify the critical region of the regulatory fragment that can drive 
expression of col2a1a. Gateway Cloning, zebrafish transgenesis, and fluorescence 
microscopy were used to determine which section of the R2 region was critical for the 
expression of col2a1a (Kawakami, 2004). Subsequently, our aim was to identify tissue 
specificity within the R2 subunits. Testing segments of the R2 regulatory region in 
isolation demonstrated whether these individual fragments were responsible for the 
specific expression in the cartilage, ear, or notochord. This process allowed for an 
inference as to whether the reporter protein expression could be activated specifically in 
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different tissues. The last step was to determine what transcription factors may be 
required for the expression pattern in each specific tissue. The isolation of a minimal 
regulatory region was crucial in the identification of transcription factor binding sites that 
were necessary for expression in that specific tissue. In silico analysis using comparative 
genomics to assess the sequences of distantly related teleosts identified highly conserved 
sequences, and potential transcription factor binding sites of interest. The importance of 
these putative transcription factor binding sites were determined using site-directed 
mutagenesis of the identified sequences. This process investigated of the interactions 
between the DNA sequence in the regulatory region and the transcription factors that 
were bound to allow for transcriptional initiation.  In  particular  if  the  smaller  
regulatory  units  were  crucial  for  expression  in different tissues of the zebrafish, we 
could begin to identify the transcription factors and their networks that were essential for 
expression in the different units of the regulatory region. 
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CHAPTER TWO 
 
MATERIALS AND METHODS 
Construction of Minimized R2 Entry Plasmids 
Amplification of the R2 minimized plasmids  
The homologous recombination technology of the Multisite Gateway vector 
system was used to construct the expression plasmids containing the dissected regulatory 
elements (Petersen and Stowers, 2011). The primers used for the amplification of the 
minimized R2 units were derived from the complementary sequence of the regulatory 
element. Additional sequences, referred to as attB sequences, were added to the flanking 
5’ end of the primers to subsequently assist with their recombination into the pDONR 
vectors. The PCR primer sets used for the amplifications are listed below. 
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Table 1. Primers for isolation of R2 minimized plasmids 
Regulatory 
Elements 
Forward Primer Reverse Primer 
AB 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCCCTCTG
ACACCTGATGCCAATTGC 
GGGGACTGCTTTTTTGTA
CAAACTTGCCAGGGGTG
TGTAGGGTGGCTGGG 
BC 
GGGGACAACTTTGTATAG
AAAAGTTGATCCAATGGC
CAGGCCCCTCATCATC 
GGGGACTGCTTTTTTGTA
CAAACTTGCGGGTGTGG
ATGGAGGGAGAGTGCG 
CD 
GGGGACAACTTTGTATAG
AAAAGTTGCTGAGCCTCT
CCGTGTTCTCCTCATCC 
GGGGACTGCTTTTTTGTA
CAAACTTGCTCTGTGTGC
AGACCTGAGGAATGTG 
DE 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC 
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC 
EF 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCCGCATT
GTGTGTGTGTCTTACAG 
GGGGACTGCTTTTTTGTA
CAAACTTGCAGGGATAT
GTGTATGTGTGTGTACG 
D 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC 
GGGGACTGCTTTTTTGTA
CAAACTTGCTCTGTGTGC
AGACCTGAGGAATGTG 
E 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCCGCATT
GTGTGTGTGTCTTACAG 
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC 
D-E1 
GGGGACAACTTTGTATAG
AAAAGTTGCTGCGGCTCT
CTTCTCCCCCACTGCC 
GGGGACTGCTTTTTTGTA
CAAACTTGAGTGCTCTGT
AAGACACAC 
D2-E 
GGGGACAACTTTGTATAG
AAAAGTTGAGTCTCTCAC
ATTCCTCAGGTCTGC 
GGGGACTGCTTTTTTGTA
CAAACTTGCGTGTGTGTG
TCCGAAATGAGCCC 
D2-E1 
GGGGACAACTTTGTATAG
AAAAGTTGAGTCTCTCAC
ATTCCTCAGGTCTGC 
GGGGACTGCTTTTTTGTA
CAAACTTGAGTGCTCTGT
AAGACACAC 
 
The previously published plasmid in Dale and Topczewski 2011 containing the 
R2 region in the 5’-entry vector was used to amplify the subunits of R2 (A-F). The PCR 
reactions contained dNTPS (200 μM each), 20 μl I- Buffer, 10 ng DNA, 2 U iProof DNA 
polymerase (BioRad), and forward and reverse primers (1 μM each) for the desired 
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subunit. The PCR program used for the amplification of the attB-flanked product is 
detailed below. 
Step 1 98°C 1 min 
Step 2 98°C 45 sec 
Step 3 60°C 45 sec 
Step 4 72°C 30 sec 
Repeat Step 2-4 x35 times 
Step 5 72°C 10 min 
Step 6 4°C 10 min 
Step  7 15°C ∞ 
 
In order to verify the amplification of the correct sequence, agarose gel 
electrophoresis was performed to confirm the size of the PCR product. The confirmed 
band length was cut from the agarose gel, and the Zymoclean Gel DNA Recovery Kit 
was used to purify the DNA. Three volumes of the agarose dissolving buffer were added 
to the gel fragment and incubated at 50°C to liquefy the solid gel to release the desired 
DNA fragment. The solution was subsequently centrifuged in a column to remove the 
agarose, while the DNA remained bound to the filter. The DNA binding filter was rinsed 
with a DNA wash buffer, and then the purified DNA was eluted. This process isolated, 
amplified, and purified the R2 minimized units with the flanking attB sequences. 
Insertion of amplified sequence in plasmid 
The purified PCR products for the subunits of R2 (AB, BC, CD, DE, EF, D, E, D- 
E1, D2-E, D2-E1) had the attB sites required for recombination into the 5’- entry vector 
in a Multisite Gateway BP reaction. A mixture with 150 ng of the PCR product, 150 ng 
of the pDONR4-1 vector, TE Buffer, and 2 μl of BP clonase enzyme was made and 
incubated overnight at room temperature. The following day the reaction was terminated 
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by the addition of 1 μl of proteinase K to the reaction. The pDONR4-1 vector had a ccdB 
gene that eliminated potential bacterial cells that contained the original pDONR plasmid, 
and did not recombine out the ccdB gene. This gene is recombined out of the vector if our 
sequences are successfully integrated. The homologous sequences between the pDONR 
vector and the attB sites on the PCR product allowed the recombination of the PCR 
product into the 5’-entry vector, which removed the ccdB gene. Bacterial cells that 
contained the entry vector with the appropriate insert proliferated, while those cells with 
the original ccdB gene were destroyed. The plasmid was added to chilled TOP10 One 
Shot chemical competent cells (Invitrogen), which was set on ice for 30 minutes. These 
cells were heat-shocked at 42°C for 90 seconds to allow for plasmid uptake into the 
bacterial cell. Super Optimal Broth with Catabolite Repression (SOC) medium was added 
to the cells and provided nutrients for the replication of bacterial cells, and in turn 
produced copies of the desired vector. After an hour in a 37°C shaking incubator, the 
bacterial cultures were centrifuged and the pellet was resuspended in 125 μl of the SOC 
medium. This concentrated bacterial culture was plated on a kanamycin antibiotic plate 
and grown overnight at 37°C to selectively allow growth of bacteria that had taken up the 
desired plasmid. The 5’-entry plasmids had a kanamycin resistance gene, so bacterial 
cells with the entry plasmids were resistant to this antibiotic. For our transformation, 
kanamycin eliminated the bacterial cells without our desired plasmid. The individual 
colonies on the agar plates were instances of bacterial cells with the minimized R2 units 
in the 5’-entry plasmid, which provided antibiotic resistance. 
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Purification of plasmid DNA from transformation 
The Zyppy Plasmid Miniprep Kit (Zymo Research) was used for the purification 
of the 5’-entry plasmids, which separated the plasmids from the components of the 
bacterial cell. At least five individual colonies from each transformation plate were 
chosen for inoculum of 2 ml liquid cultures, which were grown for 6-16 hours in a 
shaking incubator at 37°C. At least six hundred microliters of each culture were placed in 
an eppendorf tube and lysis buffer was added. The bacterial cells were lysed to release 
the plasmids into the supernatant, while the remnants of the bacterial cells formed a 
precipitate. The addition of refrigerated neutralization buffer ceased the reaction. 
Subsequently the mixture was spun down for the compression of the cellular components 
into a pellet, while the supernatant was easily separated into a spin-column. The 
replicated plasmid in the supernatant was bound to the filter, while the remaining liquid 
was drained through the spin column. The filter on the spin column was rinsed with wash 
buffers to be certain only the plasmid was bound to the filter, and then the plasmids were 
released with the addition of an elution buffer and subsequent centrifugation. The final 
product of the Zyppy Plasmid Miniprep Kit was approximately 30 μl of the 5’-entry 
plasmid with the minimized R2 units. 
Confirmation of accurate plasmid 
            The miniprep culture with the correct product was initially confirmed with the 
digestion of the plasmid with restriction enzymes. A mixture that included 400 ng of the 
plasmid, 10 units of SacI (New England Biolabs), 2 μl of Buffer 1, and 2 μl 10x BSA 
were incubated to allow for the plasmid to be cut at two sites. Gel electrophoresis 
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confirmed positive colonies that had the expected bands for the AB-EF plasmids. Each 
was predicted to give bands of 2377 bp and 387 bp on a 1% agarose gel stained with 
ethidium bromide. The correct band length on the agarose gel was visualized under 
ultraviolet light, and at least five hundred nanograms of the miniprep product were sent to 
GeneWiz Inc (South Plainfield, NJ) to be sequenced using the M13 Forward and M13 
Reverse primers. The following day the sequencing results were downloaded from 
GeneWiz, where they were analyzed using the bioinformatics tool Geneious (Biomatters 
Ltd.), to compare the sequenced results to the original R2 regulatory region sequence. 
The program displayed a visualization of the nucleotide sequences of the amplified and 
control R2 region, and was an assurance that the appropriate nucleotides were present in 
the 5’-entry vector. 
Preparation of larger volume of plasmids 
Once the sequencing results were confirmed, a greater amount and concentration 
of the DNA was accomplished with Zymo Research’s Zyppy Plasmid Maxiprep Kit. A 
1:1000 dilution of kanamycin was added to 150 μl of LB broth, and one hundred 
microliters of the miniprep culture with the confirmed band length was used as an 
inoculum of the broth. The inoculated culture was grown at 37°C overnight in a shaking 
incubator. After sixteen hours of incubation, the maxiprep culture was spun down in a 
centrifuge at 4700g for twenty minutes, which produced a bacterial pellet. The pellets 
were resuspended in 15 mL of buffer, and a lysis buffer was subsequently added. Very 
similar to the miniprep kit, the bacterial cells were lysed to release the contents of the 
cells, including the plasmid DNA, into the supernatant. The neutralization buffer was 
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added and the mixture was stored on ice for 10 minutes. The separation of the precipitate 
eliminated the components of the bacterial cell, but left the plasmids in the supernatant. 
Using the vacuum manifold method, the column attached to the vacuum removed the 
supernatant and left the plasmids attached to the filter. The column was rinsed with a 
wash buffer, which eliminated any residues that inadvertently stuck to the filter. The 
addition of three milliliters of the Zyppy Elution Buffer and centrifugation of the column 
released the plasmid. The final product of the maxiprep procedure was a higher 
concentration of the 5’-entry plasmids with the minimized R2 units. 
Construction of mutated putative transcription factor binding sites 
In a process similar to the identification of R2, comparative genomics was utilized 
to determine which nucleotides should be altered using site directed mutagenesis. By 
comparing individual nucleotides in the DE region of zebrafish, stickleback, medaka, and 
tetradon, highly conserved sequences were identified. These sequences were potential 
transcription factor binding sites, which happened to correlate to the Ets, Runx, and Sox 
families of transcription factors. Site-directed mutagenesis by PCR changed the specific 
nucleotides that were important for the binding of these transcription factors. The PCR 
primers contained the altered nucleotides within the DE sequence and amplified outward, 
which copied the entire entry vector. These primers were also phosphorylated at the 5’ 
end, which was essential for the ligation of the vector. A mutated vector was created for 
each potential transcription factor binding site individually, as well as each of the sites in 
parallel with each other. The addition of DpnI restriction enzyme (New England Biolabs) 
digested the entry vectors that were methylated. A digest with this restriction enzyme cut 
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the original methylated DE vector, while the new un-methylated mutated vectors created 
via PCR remained intact. Gel electrophoresis confirmed the correct band length of the 
PCR product was 2764 base pairs. Pending correct results, the PCR product was purified 
with Zymo Research’s Zyppy DNA Clean and Concentrator Kit. The Quick Ligation Kit 
(New England Biolabs) was subsequently used in the recircularization of the 
phosphorylated ends of the PCR product. The combination of the PCR product, deionized 
water, 10 μl 2x Buffer, and 1 μl Quick Ligase was incubated at room temperature for 10 
minutes. The reaction was put on ice until the standard transformation procedure was 
completed with kanamycin antibiotic plates. Following the transformation, cultures were 
started from individual colonies and plasmids were extracted with the Zyppy Plasmid 
Miniprep Kit. The isolated plasmids were digested with SacI (New England Biolabs) to 
confirm the correct band lengths were 2377 bp and 387 bp. The plasmids with the 
appropriate band lengths were sent out for sequencing with an M13 forward primer. 
When the results confirmed the sequence was correctly mutated, a maxiprep culture was 
prepared using the miniprep culture as the inoculum. 
Generation and Analysis of Minimized R2 Reporter Transgenic Zebrafish 
Construction of destination vector 
The final expression vector was formed from the recombination of three entry 
vectors into the final destination vector. The dissected R2 regulatory region was placed in 
5’-entry vector as described above. An adenovirus derived E1b transcriptional initiator 
with a Carp TATA-box were used as a minimal promoter was placed in the middle-entry 
vector. An enhanced green fluorescent protein (EGFP) gene was placed in the 3’-entry 
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vector, and it produced the reporter protein that was visualized by fluorescent 
microscopy. The 5’-entry vectors were constructed in the Dale laboratory; the middle-
entry and 3’-entry plasmids were obtained from the Topczewski laboratory at Lurie 
Children’s Research Center and used in previous experiments (Dale and Topczewski 
2011). Ten fentomoles of each entry plasmid, 20 fentomoles of the destination vector, 
tris-EDTA buffer, and 2 μl of LR clonase were added together for the LR reaction and 
incubated at room temperature overnight. The addition of the LR clonase enzyme assisted 
with the recombination of the entry vectors into the appropriate orientation in the final 
destination vector; the reaction was based on the attR sequences present in the plasmids. 
Proteinase K was added to the reaction and placed at 37°C for 15 minutes, which 
terminated the reaction by destroying the reaction enzymes. The final expression vector 
contained the minimized R2 regulatory unit, which drove expression of the EGFP 
reporter protein. The final expression vector was transformed into Top10 chemical 
competent bacterial cells (Invitrogen) by heat-shock, and the plasmids penetrated the cell 
wall of the bacterial cells. Five hundred microliters of LB broth was added to the 
transformed cells, and placed in a 37°C shaking incubator for one hour, which aided in 
the division of the bacterial cells and therefore generation of the transgenic plasmid. The 
bacterial culture was centrifuged into a pellet and resuspended with 125 μl of the culture, 
which gave a concentrated bacterial culture. The transformation mixture was spread on 
an ampicillin antibiotic plate and incubated overnight to selectively permit growth of the 
bacterial cells that took up the expression plasmid. The pDest final destination vector had 
an ampicillin resistant gene, which was passed onto the bacterial cells that took up the 
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plasmid. The colonies on the agar plates were the reproduction of individual cells that 
contained the expression vector with antibiotic resistance. 
The procedures used for the isolation of the entry vector plasmids were repeated 
for the production of a high concentration of the final expression vector. The Zyppy 
Miniprep Kit isolated the expression vector from the miniprep cultures with ampicillin. 
The plasmids were cut at two sites when digested with SacI (New England Biolabs), and 
the expected band lengths for gel electrophoresis were 1700 bp and 3500 bp. The 
miniprep culture with the correct digest was used for the inoculation of 150 mL of LB 
broth with ampicillin, and grown overnight at 37°C in a shaking incubator. Zymo 
Research’s Zyppy Maxiprep Kit, was used to extract the plasmid DNA, and provided 30 
μl of the final expression vector. This process was also done for the generation of the R2 
mutagenesis enhancer elements as well. An LR reaction inserted the mutated region, the 
E1b-TATA sequence, and the EGFP reporter gene into the pDestTol2 vector. The LR 
reaction was transformed and placed on ampicillin plates, and the Zyppy Plasmid 
Miniprep Kit procedure was performed on their cultures to isolate the DNA. The 
plasmids were digested with SacI (New England Biolab), and confirmed the band lengths 
were 3512 bp and 1785 bp. The miniprep culture was used to inoculate a maxiprep 
culture, and a  larger volume of the  plasmid was isolated with the Zyppy Plasmid 
Maxiprep Kit 
Zebrafish embryo microinjections 
The DNA plasmids were injected into embryos at the one-cell stage; the 
expectation was that the transgenic plasmid would be present in each of the dividing cells 
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of the developing embryo. The final expression plasmids were diluted to 80 ng/μl of 
DNA, and added to 1 μl of 4x Danio solution, 1 μl of transposase, and 1 μl of phenol red. 
The transposase assisted with the integration of the reporter sequence into the zebrafish 
genome, which aided in the establishment of a stable line for the zebrafish. Phenol red 
was essential for the visualization of the injection solution into the zebrafish embryos. 
Capillary tubes were pulled and formed a sharp needle, which penetrated the chorion and 
embryo for the injection process. The injection solution was loaded into the needles and 
placed in a microinjector. The zebrafish embryos were organized into rows on agar 
plates, and microscopes were used to observe the insertion of the needle into the embryo 
for the injection. Even though the EGFP expression pattern was visualized in the transient 
zebrafish in a mosaic fashion, a stable line was established in the next generation with the 
transposition of the transgenic sequence into the germ line cells. The zebrafish that were 
positive for the EGFP reporter protein were grown to adulthood, and then crossed with 
wild-type zebrafish. The second generation with EGFP in the tissues provided a 
confirmation of the results and displayed a clear expression pattern of the reporter 
protein. 
Imaging and analysis of transgenic zebrafish lines. 
Following the injections, the zebrafish were prepared for fixation at 5 days post 
fertilization (dpf).  Ice was added to the water in the petri dish containing the zebrafish, 
and the larval fish were subsequently collected in eppendorf tubes. The water was 
removed from the eppendorf tubes and replaced with 4% paraformaldehyde (PFA) 
(Sigma) in phosphate buffered saline (PBS). The zebrafish in PFA solution were stored 
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overnight on a compact rocker in a 4°C laboratory refrigerator. After about 16 hours in 
the cold, the 4% PFA solution was removed from the eppendorf tubes and replaced with 
PBS supplemented with 0.02% Triton-X 100 (PBS-TX) and placed on a laboratory 
rocker for 15 minutes. The PBS-TX was removed and replaced with fresh PBS-TX 
solution at least 5 times, which rinsed and removed the remainder of the PFA. The rinsed 
zebrafish were ready for scoring, and stored at 4°C when not being examined. 
The zebrafish tissues were inspected for EGFP expression under the fluorescent 
microscope. A scoring sheet was designed for the inventory of the EGFP expression in 
the tissues of the zebrafish, and one sheet was dedicated to each construct injected from 
the clutch of embryos. The top half of the scoring sheet contained images of the lateral 
view and ventral view of a zebrafish and focused on their anatomy (Haffter et. al, 1996). 
These images were used as the basis of the identification of expression in the tissues, and 
they were also marked for expression in unexpected tissues. The bottom half of the 
scoring sheet was a table used to tally the expression pattern of the zebrafish, particularly 
in the expected tissues. The table consisted of columns for expression in the notochord, 
craniofacial cartilage, ear, heart, skin, muscle, and other tissues. Based on an examination 
of each zebrafish under the fluorescent microscope, marks were made under the 
appropriate column when EGFP was present in particular tissues. The scoring permitted a 
calculation of the total number of zebrafish with EGFP in each of the tissues, which 
determined the percentage of fish that expressed the reporter gene. The zebrafish were 
also mounted on slides, and high quality images were captured with an Olympus 
Fluoview 1200 laser-confocal microscope. The images captured were at a 10x 
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magnification and a 1:1 aspect ratio with 1024 x 1024 resolution. A Z-scan captured a 
series of images of the zebrafish at different depths, which allowed for the visualization 
of EGFP expression in the various tissue layers. Images of the ventral view of the 
zebrafish head displayed the craniofacial cartilage, while the lateral view images revealed 
the ear, notochord, and craniofacial cartilage. Each construct was imaged with at least 
three fish in the ventral view, as well as a lateral view of three fish from the anterior to 
posterior end. 
Construction of Transcription Factor Expression Plasmids 
Isolation of transcription factor sequences 
The construction of the transcription factor expression vector began with the 
isolation of the RNA from a zebrafish embryo digest. Thirty-five zebrafish embryos were 
euthanized according to our IACUC approved protocol, and placed in a microcentrifuge 
tube and measured to determine the total weight. One milliliter of Invitrogen TRIzol was 
added per 50 mg of tissue, and the solution was homogenized with a syringe and spun 
down for one minute. An equivalent volume of ethanol was added to homogenate, and 
the mixture was loaded onto the spin column and spun down for one minute. Four 
hundred microliters of Direct-zol RNA pre-wash from Zymo was added to the column 
and spun down for one minute. The flow through was discarded and this process was 
repeated. Two hundred microliters of the RNA Wash Buffer was added to the column 
and the flow-through was once again discarded. The column was transferred to a new 
microcentrifuge tube, and 30 μl DNase/RNase-free water were added to the column and 
spun down for the final RNA product. The complementary DNA sequences of the 
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transcription factors were created from the zebrafish RNA using Life Technologies’ 
Superscript III Reverse Transcriptase Kit. The total RNA, primers, a dNTP mix, and 
deionized water were added to a nuclease-free microcentrifuge tube and heated for 5 min 
at 65°C, followed by an incubation for one minute at 4°C. First strand buffer, 0.1 DTT, 
and superscript III reverse transcriptase were added to each microcentrifuge tube and 
incubated at 25°C for 5 min, 50°C for 60 min, and 70°C for 15 min. The addition of 
RNase H and an incubation of 37°C for 20 minutes degraded the RNA, which left all the 
complementary DNA strands, including the sequences for our transcription factors. 
Primers were designed to isolate the sequence for the specific transcription factors from 
the total zebrafish cDNA. 
Table 2. Primers for isolation of transcription factors 
Transcription 
Factors 
Forward Primer Reverse Primer 
Ets1 
CGTTTGAATGCGTGACCAT
GACGGC 
GCAGGATTTATCCGTCAGG
AGCTCC 
Sox9a 
CCATCTACGGTGTTACCAT
GAATC 
CATTCAGGCGTGCTCATGG
TCTGG 
Runx3 
CTG TAG CCT ACT CAA 
CCA ACT G 
ATC ATG CGC AAC TCT TCT 
GGT C 
A PCR reaction using this cDNA, 1.25 μl (1μM) designated primers (Table 2), 10 μl 
iProof Buffer, 1 μl (200 μM) dNTPs, 0.5 μl (1 U) iProof polymerase, and deionized water 
were used to isolate the desired transcription factor sequence with the following protocol: 
Step 1 98°C 1 min 
Step 2 98°C 30 sec 
Step 3 60°C 30 sec 
Step 4 72°C 45 sec 
Repeat Step 2-4 x34 times 
Step 5 72°C 10 min 
Step 6 4°C 10 min 
Step 15°C ∞ 
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The product of this PCR reaction was run on a 1% low melt agarose gel, and 
subsequently separated and purified using the Zymoclean Gel DNA Recovery Kit. The 
isolated DNA was used in a second PCR reaction, which amplified the same transcription 
factor sequence with different primers that contained attB sites (Table 3). The PCR 
product was again run on a 1% low melt gel, and the correct bands were once again 
separated using Zymoclean Gel DNA Recovery Kit. 
 
Transcription factor sequence inserted into middle-entry vector 
Using Gateway Technology, the isolated DNA sequence of the transcription 
factors were inserted into the middle-entry vector using a BP reaction. The gel purified 
PCR products had the appropriate attB sites for recombination into the middle-entry 
vector. A mixture of 150 ng of the PCR product, 150 ng of the pDONR 221 vector, TE 
Buffer, and 1 μl of BP clonase enzyme were added and incubated at room temperature 
overnight. The following day 1 μl of proteinase K was added to terminate the reaction 
with a 15 minute incubation at 37°C. This reaction generated middle-entry vectors with 
Table 3. Primers with attB sites for isolation of transcription factors 
Transcription 
Factors 
Forward Primer Reverse Primer 
Ets1* 
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGCGTTTGAATGC
GTGACCATGACGGC 
GGGGACCACTTTGTACAAGAA
AGCTGGGTAGCAGGATTTATC
CGTCAGGAGCTCC 
Sox9a* 
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGCCATCTACGGT
GTTACCATGAATC 
GGGGACCACTTTGTACAAGAA
AGCTGGGTACATTCAGGCGTG
CTCATGGTCTGG 
Runx3* 
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGTTGTGATGCAT
ATTCCCGTAGACC 
GGGGACCACTTTGTACAAGAA
AGCTGGGTATCTTAGTACGGC
CTCCAGACAGAC 
Fli1a 
GGGGACAAGTTTGTACAAAAA
AGCAGGCTAGTTGTGATGCAT
ATTCCCGTAGACC 
GGGGACCACTTTGTACAA 
GAAAGCTGGGTATCTTAGTAC
GGCCTCCAGACAGAC 
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the newly inserted PCR product, which was then transformed into bacterial cells. The 
middle-entry plasmids had a kanamycin resistance gene, therefore the colonies on the 
antibiotic- agar plates were indicative of bacterial cells with the desired plasmid. 
Isolation of middle-entry plasmids 
The Zyppy Plasmid Miniprep Kit standard procedure isolated the middle-entry 
plasmids for the DNA sequence of sox9a, ets1, and runx3. The middle-entry vector for 
ets1 was digested with  SacI (New England Biolabs) for the expected band sizes of 29998 
bp and 585 bp. The expected bands for sox9a when digested with ApaLI (Fermentas) 
were 2295 bp and 1671 bp. The middle-entry vector for runx3 was digested with HincII 
(New England Biolabs), and the expected band lengths were 3154 bp and 675 bp. The 
bands that travel the correct distance according to the ladder had the potential to be 
accurate, so they were sent out for sequencing. Five hundred nanograms of the plasmids 
were sent out to GeneWiz for sequencing with the M13 forward and M13 reverse primers 
to determine the accuracy of the sequences. When the sequence accuracy was confirmed, 
100 μl of the corresponding miniprep culture was used to inoculate 150 mL of LB broth 
with kanamycin. Standard maxiprep procedures with the Zyppy Plasmid Maxiprep Kit 
isolated a large volume of the desired plasmid. 
Transcription factor expression vectors 
Gateway technology was once again employed to insert the transcription factor 
sequence into the final expression vector with homologous recombination. A mixture of 
150 ng of the middle-entry vector with the transcription factor sequence, 150 ng of the 
pCSDest vector, TE Buffer, and 1 μl LR clonase enzyme were added together and 
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incubated at room temperature overnight. The following day, 1 μl of proteinase K was 
added to the reaction with a subsequent 15-minute incubation at 37°C to terminate the 
reaction. The expression vector was transformed into bacterial cells, and the ampicillin 
plates were incubated overnight at 37°C. Individual, isolated colonies from the bacterial 
plates were used to make 2 mL bacterial cultures and the Zyppy Plasmid Miniprep Kit 
was used for the isolation of the plasmids. The plasmids from the miniprep protocol were 
digested with various restriction enzymes to check the lengths of the bands. The 
expression vector for runx3 was digested with HincII (New England Biolabs), with the 
correct band lengths of 3154 bp and 675 bp. A PvuII (New England Biolabs) digested the 
expression vector of ets1a, which formed two bands of 3661 bp and 1531 bp. Also, the 
expression vector of sox9a was digested with ApaLI (Fermentas), with accurate bands 
lengths of 2579 bp, 1750 bp, and 1246 bp. For the DNA with the correct band lengths, 
the corresponding miniprep culture was used to inoculate 150 mL of LB broth with 
ampicillin. This culture was used for the Zyppy Maxiprep Plasmid Kit and the isolation 
of the desired plasmids. 
Generate transcription factor mRNA 
The transcription factor expression vectors were digested with the appropriate 
restriction enzymes, purified with phenol:chloroform, and finally RNA was synthesized 
using the mMessage mMachine Kit (Life Technologies). Ten micrograms of the 
expression vectors for Runx3, Ets1, and Sox9a were digested with NotI into 100 μl 
reactions, and incubated for three hours. After digestion, the volume was brought up to 
200 μl with RNA-free water. An equal amount of phenol:chloroform:isoamyl alcohol was 
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added to the solution. Each tube was centrifuged at 16,000g for 5 minutes. When the 
aqueous layer was recovered, 200 μl of chloroform was added to the solution, centrifuged 
again for 3 minutes and repeated. The upper aqueous layer was once again recovered and 
the DNA was precipitated with the addition of 20 μl of sodium acetate and 500 μl of 
ethanol. This solution was mixed and incubated at 20°C for 30 minutes and subsequently 
spun down at 4°C for 20 minutes at 16,000g. The supernatant was discarded and the tube 
was left to dry. Five hundred microliters of 70% ethanol was added to the tubes and spun 
down at 4°C for 10 minutes at 16,000g. The sample was resuspended with 25 μl of 
RNAse free water. Finally, the sample was run on a 1% agarose gel to verify the presence 
and accuracy of the results. This process provided the purified transcription factor 
expression vectors, but the synthesis of the RNA can be completed with the mMessage 
mMachine Kit (Life Technologies). The following solutions were added to an eppendorf 
tube and incubated at 37°C for 2 hours: 10 μl 2x NTP/CAP, 2 μl 10x reaction buffer, 1 μg 
isolated DNA, 2 μl of the enzyme mix, and RNAse free water if necessary. Any 
remaining DNA was eliminated with the addition of 1 μl TURBO DNAse (Ambion), 
which was added to each tube and incubated at 37°C for 15 minutes. The RNA product 
was purified using NucAway spin column (Ambion), which placed the sample on the 
hydrated gel bed and spun the column in a centrifuge at 750g for 2 minutes. This 
completed the synthesis of the transcription factor RNA, which was prepared for 
microinjections. 
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Zebrafish embryo microinjections 
The RNA of the transcription factors was injected into the embryos at the one-cell 
stage, which was at an earlier stage than the genes endogenous period of transcription. 
The transcription factor mRNAs were diluted to 300 ng/μl of RNA, and added to 4x 
Danio solution and phenol red. The mixture of transcription factor RNA was injected into 
the stable line R2-DE embryos, which would produce the protein and theoretically 
initiated transcription of the EGFP reporter gene. The binding of the transcription factors 
to the DE region would be confirmed with the presence of the reporter protein prior to 
normal expression. 
Zebrafish Husbandry 
            Zebrafish housing and care was maintained as per LeClair et al. (2009) for wild-
type and transgenic zebrafish lines in the vertebrate animal care facility at Loyola 
University Chicago (Chicago, IL). A natural spawning technique was used to obtain 
embryos for these experiments, and they were staged according to Kimmel et al. (1995). 
Zebrafish for these experiments were scored based on the morphology labeled by 
Kimmel et al. (1995). The protocols and care of the zebrafish were approved by IACUC 
of Loyola University Chicago (Chicago, IL). 
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CHAPTER THREE  
RESULTS 
Identification of R2-DE as the col2a1a Regulatory Region 
Our laboratory has previously identified a critical zebrafish regulatory sequence 
of the col2a1a gene, referred to as R2, allowing for the expression of Col2a1a protein in 
the craniofacial cartilage, ear, and notochord utilizing zebrafish transgenic report analysis 
(Dale and Topczewski 2011). To identify what segment of the R2 unit is critical for tissue 
specificity, we set out to dissect the previously identified sequence. To be able to 
compare my work to that of the previous transgenic reporter analysis, I repeated the 
original Dale and Topczewski 2011 transient transgenic R2 experiments to demonstrate 
my technique was similar to the original work. During my study, the injections completed 
with the original R2 transgenic plasmid had EGFP reporter expression in about 30% of 
the embryos (Table 4). When compared, there seemed to be no difference in expression 
pattern compared to the original work, allowing us to set out to dissect the R2 element. 
While the identification of the R2 regulatory element was originally based on its 
ability to recapitulate expression in critical tissues, it was also based on a teleost fish 
conserved sequence of 360 bp, which could contain many overlapping transcription 
factor binding sites. We set out to minimize the R2 regulatory element to determine 
exactly which bases of the original 360 are responsible for the transcriptional regulation 
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of col2a1a.  To do this we utilized a combination of Gateway cloning, zebrafish 
transgenesis, and fluorescence microscopy to identify the critical sequence for gene 
expression. The R2 regulatory region was divided into 5 overlapping fragments (AB, BC, 
CD, DE, EF), and placed upstream of an EGFP reporter gene. The first 120 bp of the R2 
regulatory region, AB, was not able to drive expression of the reporter protein when 
examined under the fluorescent microscope (Figure 3). Of the 233 embryos that were 
injected and scored at 5 days post fertilization (dpf), none of the juvenile zebrafish 
expressed the reporter protein in the craniofacial cartilage and only one EGFP positive 
cell was observed in the ear and notochord in one zebrafish, suggesting that zebrafish to 
be a statistical outlier when the overall totals were compiled (Table 5). The embryos 
injected with the plasmid driven by the BC subunit also lacked expression of the reporter 
protein (Figure 4). There were no embryos with expression in the notochord of the 191 
embryos injected (Table 6). There were two zebrafish with slight expression in the 
craniofacial cartilage and one with expression in the ear, but again this was not 
statistically significant. These injections eliminated the first 180 bp of the R2 element 
responsible for the majority of col2a1a expression. Of the 150 embryos injected with the 
reporter plasmid that was driven by the CD subunit, there was no evident EGFP 
expression when examined and scored under the fluorescent microscope (Table 7; Figure 
5). EGFP expression was present in all expected tissues of the zebrafish injected with the 
DE subunit and recapitulated the original R2 expression pattern seen (Figure 6). Of the 
221 total zebrafish embryos injected with the DE construct, about 30% of the zebrafish 
expressed the EGFP reporter in the craniofacial cartilage, ear, and notochord (Table 8). I 
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also did notice reporter expression in cranial neurons in these transient transgenic lines as 
was seen in the original transient R2 element characterization, but this expression was 
lost in the stable lines. The results of these DE injections paralleled the expression 
patterns of my initial experiments of the entire R2 region. Finally, when the expression of 
the reporter plasmid was driven by the EF subunit, there was again no fluorescent seen in 
109 of the zebrafish examined and scored (Table 9; Figure 7). Even though the embryos 
injected with the CD and EF subunit vectors had no visible fluorescent protein under the 
dissecting microscope, when these embryos were imaged using a laser-confocal 
microscope, there seemed to be only a faint outline of possible expression in the 
craniofacial cartilage. This was interesting because the CD and EF reporter plasmids each 
contained half of the DE subunit, which seems sufficient to phenocopy R2 activity in the 
desired tissues. Even though the CD region contained the D region, and EF contained the 
E region, it was not sufficient to drive expression like the DE region. 
To test if either the D or E region could alone drive reporter activity and therefore 
be the critical sequence of the regulatory region, the DE regions were split into 60 bp 
enhancer fragments regulating the expression of EGFP (Figure 9). Reporter plasmid 
expression driven with the R2-D unit did not yield GFP positive tissues in the 44 
embryos injected (Table 13). Of the 44 embryos injected with the R2-E unit only 2% had 
EGFP expression in the notochord, 5% in the craniofacial cartilage, and no expression in 
the ear (Table 14). Neither unit D nor unit E was sufficient to drive expression of the 
EGFP reporter protein (Figure 13, 14). This suggests that when this DE regulatory region 
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was split in half, and formed these D and E units, it eliminated important potential 
transcription factors binding affinities. 
Unlike the DE subunit, the reporter plasmids with the remaining R2 conserved 
genomic sequence (AB, BC, CD, and EF) were not able to drive expression of the EGFP 
reporter. The minimal R2 regulatory region was 120 bp in the DE region, and was 
sufficient to drive expression of the reporter protein in most of the tissues that col2a1a 
has been observed (Figure 6). These results reduce the functional transcriptional 
regulation element region of R2 to 120 bp. Multiple stable transgenic lines were 
generated with the DE transcriptional element regulating EGFP expression to confirm our 
initial findings. I found that the stable R2-DE transgenic zebrafish expression was the 
same as the full R2 stable transgenics (Figure 8). These results demonstrated the critical 
region for driving col2a1a in the cartilage, notochord, and ear resided in the R2-DE 
sequence. 
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R2 
GCCCTCTGACACCTGATGCCAATTGCGGTCAGTGTTTTGCTGGCGACACA
GATTCTTGTGCCAATGGCCAGGCCCCTCATCATCTGATCCGCAGCAACCC
AGCCACCCTACACACCCCTGGAGCCTCTCCGTGTTCTCCTCATCCCTCTAC
CTTTCCGCACTCTCCCTCCATCCACACCCGCGGCTCTCTTCTCCCCCACTG
CCCGGTGCTCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTG
TGTGTCTTACAGAGCACACAGTCAGGGCTCATTTCGGACACACACACACA
TCCAACAGGGTGTGTGCACAGTCGCAGCGATGCGTACACACACATACACA
TATCCCT 
Zebrafish Chromosome 8 
Exon 1 Exon 2 Exon 3 
   
 
 R2 
1.7 kb 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
Table 4. Results of R2 injections. 
R2 
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
3/20 4 2 50% 2 50% 1 25% 
2/28 67 20 30% 17 25% 10 15% 
Total 71 22 31% 19 27% 11 15% 
 
A 
B 
C 
Figure 1. R2 Regulatory Region Sequence and Results. (A) Schematic of the location of the R2 
regulatory region on zebrafish chromosome 8. (B) Genomic sequence of R2 regulatory region. 
(C) Injection of R2 driving expression of EGFP reporter gene, lateral view of zebrafish at 5dpf.  
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R2 
 
GCCCTCTGACACCTGATGCCAATTGCGGTCAGTGTTTTGCTGG
CGACACAGATTCTTGTGCCAATGGCCAGGCCCCTCATCATCTG
ATCCGCAGCAACCCAGCCACCCTACACACCCCTGGAGCCTCTC
CGTGTTCTCCTCATCCCTCTACCTTTCCGCACTCTCCCTCCATC
CACACCCGCGGCTCTCTTCTCCCCCACTGCCCGGTGCTCTCTCA
CATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCT
TACAGAGCACACAGTCAGGGCTCATTTCGGACACACACACAC
ATCCAACAGGGTGTGTGCACAGTCGCAGCGATGCGTACACAC
ACATACACATATCCCT 
A B C D E F 
AB CD EF 
BC DE 
60 bp 
 
   
 
 
Exon 1 Exon 2 Exon 3 
R2 
Figure 2. Minimization of R2 regulatory region. (A) Schematic depicting the dissection of the 
R2 regulatory region, including 60 bp fragments and 120 bp overlapping fragments. (B) 
Genomic sequence of R2 regulatory region with colors based on the smaller R2 fragments 
(Blue-A; Red-B; Green-C; Purple-D; Orange-E; Yellow-F) 
A 
B 
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Table 5. Results of zebrafish injected with R2-AB plasmid.  
AB 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
2/21 17 1 6% 0 0% 1 6% 
2/27 36 0 0% 0 0% 0 0% 
3/22 34 0 0% 0 0% 0 0% 
3/28 146 0 0% 0 0% 0 0% 
Total 233 1 0% 0 0% 1 0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Results of R2-AB plasmid injections. No EGFP expression with R2-BC driving 
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of 
zebrafish head, mid-section, and trunk respectively at 5 dpf.  
D 
A 
B C 
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Figure 4. Results of R2-BC plasmid injections. No EGFP expression with R2-BC driving 
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of 
zebrafish head, mid-section, and trunk respectively at 5 dpf.  
Table 6. Results of zebrafish injected with R2-BC plasmid. 
BC 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
2/27 34 0 0% 0 0% 0 0% 
3/22 45 0 0% 1 2% 0 0% 
3/24 112 0 0% 1 1% 1 1% 
Total 191 0 0% 2 1% 1 1% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
D 
B C 
37 
 
 
  
Table 7. Results of R2-CD driving expression of EGFP. 
CD 
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
2/21 117 0 0% 0 0% 0 0% 
2/28 33 0 0% 1 3% 0 0% 
Total 191 0 0% 1 1% 0 0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Results of R2-CD plasmid injections. No of EGFP expression with R2-CD driving 
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of 
zebrafish head, mid-section, and trunk respectively at 5 dpf.  
D 
A 
C B 
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Table 8. Results of R2-DE driving expression of EGFP reporter gene. 
DE 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
2/21 67 6 9% 6 9% 6 9% 
2/27 62 18 29% 18 29% 17 27% 
2/28 92 43 47% 49 53% 49 53% 
Total 221 67 30% 73 33% 72 33% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Results of R2-DE plasmid injections. EGFP present in craniofacial cartilage, ear, 
and notochord. (A) Chondrocytes highlighted by EGFP expression in craniofacial cartilage. 
Ventral view of zebrafish at 5 dpf. (B) Lateral view of zebrafish tail at 5 dpf depicting 
expression of EGFP in notochord. (C) EGFP expression in craniofacial cartilage, ear, and 
notochord visible in lateral view of zebrafish head at 5 dpf. (continued on next page) (D) 
Zebrafish midsection at 5 dpf showing expression of EGFP in notochord. 
A 
B 
39 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. (continued) Results of R2-DE plasmid injections. EGFP present in craniofacial 
cartilage, ear, and notochord. (A) Chondrocytes highlighted by EGFP expression in 
craniofacial cartilage. Ventral view of zebrafish at 5 dpf.  (B) Lateral view of zebrafish tail at 
5 dpf depicting expression of EGFP in notochord. (C) EGFP expression in craniofacial 
cartilage, ear, and notochord visible in lateral view of zebrafish head at 5 dpf. (continued on 
next page) (D) Zebrafish midsection at 5 dpf showing expression of EGFP in notochord. 
C 
D 
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Table 9. Results of R2-EF driving expression of EGFP. 
EF 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
2/21 41 0 0% 1 2% 0 0% 
2/27 22 0 0% 1 5% 0 0% 
2/28 46 1 2% 0 0% 0 0% 
Total 109 1 1% 2 2% 0 0% 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Results of R2-EF plasmid injections. No of EGFP expression with R2-EF driving 
expression. (A) Ventral view of craniofacial cartilage at 5 dpf. (B,C,D) Lateral view of 
zebrafish head, mid-section, and trunk respectively at 5 dpf.  
D 
A 
B C 
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Figure 8. Results of R2-DE stable line. EGFP expression in R2-DE stable line zebrafish. (A) 
Ventral view of craniofacial cartilage at 5 dpf. (B) Lateral view of zebrafish craniofacial 
cartilage with EGFP highlighting the chondrocytes.  
A 
B 
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Figure 8. (continued)  Results of R2-DE stable line. Images of the EGFP expression in the R2-
DE zebrafish stable line. (C) Lateral view of zebrafish head at 5 dpf. Expression of EGFP 
present in the craniofacial cartilage, ear, pec fin. (D) 20x magnification of zebrafish ear 
expressing reporter. (E) Lateral view of EGFP expression in the zebrafish notochord. 
C 
D 
E 
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Tissue Specificity of R2-DE Regulatory Region 
  The identification of the 120 bp col2a1a R2-DE regulatory region that 
recapitulates the cartilage, ear, and notochord expression of the full R2 allows us to try 
and determine what parts of this 120 bp sequence is critical for its tissue specificity. To 
do this we divided the DE region into smaller fragments which will provided us with the 
ability to dissect the tissue specificity in this regulatory unit. The DE unit was divided 
into three fragments (Figure 9). The first regulatory fragment, D-E1, encompassed all of 
D and the first 30 bp of the E region. Of the 131 embryos injected, the expression 
plasmid driven by this fragment showed a decline in the expression level of the notochord 
to 7% and ear expression was down to 8% (Figure 10). The craniofacial cartilage 
expression was more than double compared to the other tissues, with expression of the 
reporter protein in about 20% of the zebrafish. With the elimination of the last 30 bp of 
the E regulatory region, the expression levels of the notochord and ear were decreased 
(Table 10). The second regulatory fragment, D2-E, encompassed the last 30 bp of D 
region and all of the E region. Two hundred and fifteen embryos were injected with the 
D2-E reporter and subsequently scored for expression (Table 11). Of the zebrafish 
embryos injected, about 25% of the zebrafish had fluorescence in the notochord, 62% in 
the craniofacial cartilage, and 45% in the ear. Even though the notochord expression was 
slightly lower than expected, the expression of the craniofacial cartilage and ear was 
maintained with this 90 bp region (Figure 11). The third regulatory element consisting of 
the center region of the DE region, D2-E1 (Figure 9). Even though the D2-E1 region was 
minimized to only 60 bp, there continued to be EGFP expression in the craniofacial 
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cartilage and ear similar to what was seen with the full R2-DE regulatory region (Table 
12). The EGFP reporter protein was present in the craniofacial cartilage for about 49% of 
the embryos injected and scored, and also expressed in the ear for about 25% of the 
zebrafish (Figure 12). While expression in these two tissues was maintained, reporter 
protein expression was completely lost in the notochord, which was down to only 3% of 
the zebrafish.  
 The minimization of the DE region to 60 bp still maintained reporter fluorescence 
in the tissues, which implied the regulatory element of col2a1a expression in the 
craniofacial cartilage and ear is in the R2-D2-E1 sequence.    
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60 bp 
A 
Figure 9. Minimization of the R2-DE Sequence. (A) Schematic depicting where DE is located 
in relation to R2 regulatory region, as well as the relative location of the minimized R2-DE 
regions (D-E2; D2-E; D2-E1). (B) The sequence of the DE region. The gold sequence is the D 
region, while the orange sequence is the E region. The D1 and the E1 region are bolded. 
DE 
 
GCGGCTCTCTTCTCCCCCACTGCCCGGTGCTCTCTCACATTC
CTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTAC
AGAGCACACAGTCAGGGCTCATTTCGGACACACACAC 
B 
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Table 10. Results of injections with D-E1 driving expression. 
D
-E
1
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
3/27 51 5 10% 15 29% 6 12% 
3/28 80 4 5% 11 14% 4 5% 
Total 131 9 7% 26 20% 10 8% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Results of R2: D-E1 plasmid injections. (A) Ventral view of zebrafish head 
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head 
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral 
view of zebrafish trunk with no EGFP expression (5 dpf). 
A 
B C 
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Table 11. Results of injections with D2-E driving expression. 
D
2
-E
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
3/27 50 3 6% 19 38% 3 6% 
3/28 7 1 14% 2 29% 1 14% 
4/4 63 8 13% 40 63% 32 51% 
5/29 95 30 32% 73 77% 61 64% 
Total 215 42 20% 134 62% 97 45% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B C 
Figure 11. Results of R2: D2-E plasmid injections. (A) Ventral view of zebrafish head 
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head 
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral 
view of zebrafish trunk with EGFP expression (5 dpf). 
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Table 12. Results of injections with D2-E1 driving expression. 
D
2
-E
1
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
4/4 140 9 6% 65 46% 57 41% 
5/29 196 5 3% 50 26% 27 14% 
6/12 198 2 1% 146 74% 70 35% 
6/12 161 3 2% 82 51% 22 14% 
Total 695 19 3% 343 49% 176 25% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B C 
Figure 12. Results of R2: D2-E1 plasmid injections. (A) Ventral view of zebrafish head 
depicting EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head 
showing faint expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral 
view of zebrafish trunk with no EGFP expression in the notochord (5 dpf). 
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Table 13. Results of injections with D region driving expression. 
D
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
# of GFP 
Positive 
% of GFP 
Positive 
3/20 5 0 0% 0 0% 0 0% 
3/22 39 0 0% 0 0% 0 0% 
Total 44 0 0% 0 0% 0 0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B C 
Figure 13. Results of R2: D plasmid injections. (A) Ventral view of zebrafish head depicting 
no EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head 
showing no expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral view 
of zebrafish trunk with no EGFP expression in the notochord (5 dpf). 
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Table 14. Results of injections with E region driving expression. 
E
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
3/27 44 1 2% 2 5% 0 0% 
Total 44 1 2% 2 5% 0 0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 14. Results of R2: E plasmid injections. (A) Ventral view of zebrafish head depicting 
no EGFP expression in the craniofacial cartilage. (B) Lateral view of the zebrafish head 
showing no expression in the craniofacial cartilage and ear of the zebrafish. (C) Lateral view 
of zebrafish trunk with no EGFP expression in the notochord (5 dpf). 
 
C 
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Identification of Transcription Factors Binding to Regulatory Region 
It is well known that when one compares homologous regions of genomes from 
related animals that the protein coding exons can be well conserved at rates upwards of 
75% due in part to mutations in exons leading to non-functional proteins critical for 
survival. Previous work has shown that there are regions of the genome not in exons that 
seem to be conserved over evolution at rates similar to exons, suggesting that these non-
coding DNA sequences are also critical for survival (Sakabe et al., 2012; ENCODE 
Project Consortium, 2012). Many of these conserved non-coding DNA sequences have 
been found to have required transcription factor binding sites that regulate gene 
expression. We originally identified the R2 regulatory region by comparison of 12kb of 
genomic sequence surrounding the transcriptional start site of col2a1a gene of various 
teleost fish. Of the highly conserved sequences, the R2 region was able to recapitulate 
most of the expression pattern of col2a1a in the cartilage, ear, and notochord. The 
reduction of the R2 regulatory element determined that R2-DE was the most important 
region for the regulation of this gene. A comparative genomics approach of teleosts was 
again utilized but this time concentrated on short nucleotide sequences, which could 
determine exactly which transcription factors are binding to these regions. Since the 120 
bp DE region was sufficient to recapitulate the expression seen with the entire 360 bp R2 
regulatory region, we focused on this region to be compared among four teleost fish: 
medaka, stickleback, fugu, and zebrafish. Within the 120 bp sequence there were six 
regions of highly conserved nucleotide sequences, with many of them located within the 
D2-E1 region. Because of our focus on cartilage development we concentrated our 
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analysis on the D2-E1 region. The conservation of these sequences suggested they were 
the potential transcription factor binding sites regulating the expression of the col2a1a 
gene. The preference of transcription factors to bind to specific sequences allowed for in 
silico identification of potential proteins that would bind to the known conserved 
sequence. 
Using basic bioinformatic tools for identifying transcription factor binding sites, I 
analyzed the R2-DE sequence. This resulted with a substantial amount of potential 
transcription factor binding sites in this region. In order to filter through the results, I 
focused on the three conserved regions completely in the D2-E1 sequence and analyzed  
them using the JASPAR database to identify high scoring transcription factor binding 
profiles that also where shown to play a role in cartilage formation. I used JASAR to 
compare the conserved DNA sequence against known transcription factor binding 
matrices. This allowed JASPAR to compute a relative score for putative candidates. The 
closer the score is to 1, the higher the conservation/possible binding of the transcription 
factors. The first highly conserved sequence, CATTCCTCAGGTC, is linked to the Ets 
family of transcription factors with a relative score of 0.9160. The second highly 
conserved sequence, TGCACACAGAG, was associated with the Runx family of 
transcription factors with a relative score of 0.8137. The third highly conserved sequence, 
ATTGTGTGTG, was associated with the Sox family of transcription factor with a 
relative score of 0.8430. While JASPAR does suggest what exact transcription factor has 
the best match to the analyzed sequence, we and others have found that these programs 
tend to better identify families because of transcription factors being slightly flexible 
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(transcription factor wobble) in what sequence they bind (Spitz and Furlong, 2012; Ko 
and Engel, 1993). Based on the results of the database, Ets, Runx, and Sox transcription 
factor families were potentially key regulators of the R2-D2E1 region. As previously 
discussed, Runx2 and Sox9 transcription factors play an important role in chondrogenesis 
in many animals (Flores et al., 2006; Yan et al., 2005). The identification of the specific 
Ets transcription factor is more difficult to decipher because of the size of the family and 
multiple members are expressed at the right time and place, but Fli1a was our primary 
candidate based on its expression pattern in the pharyngeal arches at the appropriate 
developmental stage.  
Mutagenesis of Putative R2-DE Transcription Factor Binding Sites  
I hypothesized that the R2-DE region contained transcription factor binding sites 
for Fli1a, Sox9a, and Runx2b, and these transcription factors played important roles in 
the regulation of col2a1a. This candidate gene approach was based off the current 
literature and known expression patterns. The sequence logos generated by JASPAR 
allowed us to identify nucleotides of the conserved genome sequences that must be 
conserved for each transcription factor binding site, as well as locations of flexibility. We 
next set out to mutate the key bases in our R2-DE EGFP reporter plasmids to determine if 
our identified conserved sequences are necessary for R2-DE gene regulatory activity. By 
using these mutated plasmids to generate transient transgenic reporter zebrafish a lack of 
EGFP in the proper tissue would demonstrate the importance of the original sequence in 
the binding of transcription factors.  
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I first mutated the putative Ets-family binding site, from the core TTCC to GGAA 
(Figure 16). The TTCC nucleotide sequence seemed to be particularly important for Ets 
family member binding based on its sequence logo. Of the 280 fish injected, 75% of the 
embryos had EGFP expression in the craniofacial cartilage and 59% showed expression 
in the ear (Table 15). The notochord also had EGFP expression in about 33% present of 
the embryos. The four nucleotides mutated did not seem to negatively affect the 
expression level in the notochord or the cartilage (Figure 20), but potentially enhanced 
expression. The mutagenized Runx-family binding site altered five nucleotides changing 
the sequence from ACACAGA to GTCTAGC. Once again the expression levels of the 
notochord and craniofacial cartilage were not affected in the 240 embryos injected 
(Figure  17).  Forty  percent  of  the  zebrafish  expressed  the  reporter  protein  in  the 
notochord, and 33% expressed the protein in the craniofacial cartilage (Table 16) 
comparable to normal R2-DE activity. The expression in the tissue of the ear was present 
in about 16% of the zebrafish, which was slightly lower than the tissues of notochord and 
craniofacial cartilage (Figure 21). The Sox-family core binding site was mutated from 
TGTGT to CTCGG to prevent the family of transcription factors from binding (Figure 
18). Similar to the other mutagenized plasmids described above, the notochord, 
craniofacial cartilage, and ear expression levels of the Sox-family mutated binding site 
remained steady (Figure 22). One hundred and seventy-eight embryos were injected with 
this mutagenized plasmid and there was EGFP expression in the notochord of 45% of the 
zebrafish, 51% in the craniofacial cartilage, and 25% of the ear (Table 17). 
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The mutagenesis of the putative transcription factor binding sites individually did 
not affect the expression level of EGFP in the cartilage, ear, and notochord tissues. This 
was not surprising with the close proximity of these three conserved putative 
transcription factor binding sites, and it is highly possible that protein-protein interactions 
could still recruit the appropriate transcription factors, even with their inability to bind the 
DNA anymore. Research by other groups has demonstrated that there are protein-protein 
interactions between the Ets, Runx, and Sox family of transcription factors (Deramaudt et 
al., 2001; Huang et al., 2009). To destabilize this putative three part regulation complex, 
we next mutated different combinations of the three conserved binding sites. It was not 
until two of the putative binding sites were mutated together, that a decrease in the 
expression level of EGFP was seen in the tissues of interest. When the potential Sox and 
Ets binding sites were mutated in conjunction with each other, the EGFP expression 
levels were decreased in cartilage, notochord, and ear (Figure 23). Of the 311 embryos 
injected, only 13% of the zebrafish expressed EGFP in the craniofacial cartilage and 5% 
in the ear (Table 18). The zebrafish injected with the plasmid expressed the reporter 
protein in the notochord for only 22 fish, or 7% of the zebrafish. Similar to these results, 
the mutagenesis of the Ets and Runx binding sites also decreased the expression levels of 
the reporter protein (Figure 24). The EGFP expression level in the notochord was only in 
9% of  zebrafish,  18%  in  the  craniofacial  cartilage,  and  7%  in  the  ear  (Table  19).  
By mutating these sequences of the potential binding sites we were able to disrupt the 
effective binding of the transcription factors to the DNA, and in turn minimized the 
likelihood of the R2-DE regulatory region to initiate transcription of the reporter gene. 
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When the Runx and Sox binding sites were mutated in the plasmid, EGFP was present in 
the notochord of 29% of fish, 31% in the craniofacial cartilage, and 11% in the ear 
(Figure 25; Table 20). The percentage of zebrafish that expressed EGFP in the 
appropriate tissues was not significantly decreased by the mutagenesis of the plasmids at 
these two sites. 
Increase Activity in Mutated Ets-family Binding Site 
The percentage of zebrafish with expression in the craniofacial cartilage was 
much higher for zebrafish injected with the plasmids mutated at the Ets binding site. 
Initially in silico analysis and literature searches suggested the possibility of Ets1 binding 
to the DE region, which was how the mutations were designed. Further analysis revealed 
the possibility of Fli1a, an Ets family member, as a potential candidate also due to its 
expressed in the correct tissue at the right time during development. A review of the Ets 
mutagenesis revealed the transgenic reporter plasmids possibly contained a better binding 
sequence for Fli1a. This finding was a potential explanation for the large percentage of 
zebrafish that expressed EGFP in the craniofacial cartilage when injected with this 
plasmid. The plasmid with the Ets mutated binding site seemed to up-regulate the 
transcription of the reporter protein because it was better able to bind to the regulatory 
region. In order to account for this, the mutation was repeated at the same site, but altered 
to different nucleotides. The CATTCC sequence was mutated to TGCATG, which altered 
the nucleotides to theoretically no longer allow the binding of Ets1 or Fli1a. Plasmids 
were created in combination as well as alone. The Runx and Sox binding site mutations 
remained the same from the previous mutagenesis. The plasmid with the Ets/Fli1a 
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binding site mutated was injected into 410 zebrafish, and 66% expressed the reporter 
protein in the craniofacial cartilage, 47% in the ear, and 36% percent in the notochord 
(Figure 26; Table 21). Once again, the binding site mutation did not significantly 
decrease the percentage of embryos that expressed EGFP. Similar to the previous 
mutagenesis, when Fli1a and Runx binding sites were mutated simultaneously, it 
decreased the percentage of zebrafish with reporter plasmid expression (Figure 27). There 
were 677 zebrafish injected with this mutated plasmid; only 1% expressed the reporter 
protein in the notochord, 3% in the craniofacial cartilage, and 5% in the ear (Table 22). 
This data shows that the two mutations to the Ets family binding site, and the Ets binding 
site in conjunction with the Runx site had very similar results. A change came with a 
mutation to the Ets and Sox binding sites. The mutation to the Ets/Fli1a binding site, 
together with the mutated Sox binding site, was injected into 168 zebrafish (Table 23). 
Thirty nine percent of the zebrafish expressed the reporter protein in the craniofacial 
cartilage, 15% in the notochord, and 18% in the ear (Figure 28). The initial mutation 
decreased the amount of zebrafish expressing the reporter plasmid, but the new mutation 
to the Ets/Fli1a and the Sox binding site did not have the same results. 
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A 
B 
Figure 15. Sequence Conservation Schematic. Images depicting sequence conservation 
and putative transcription factor binding sites. (A) The image is a comparison of 
zebrafish and stickleback, but analysis also includes comparisons with tetradon and 
medaka. There seems to be Ets, Runx, and Sox Transcription factor binding sites. (B) 
Image of the binding sites based on the zebrafish genome, as well as the mutations that 
were made to the sequence.  
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Figure 16. Ets-Binding Site Mutation Schematic. The potential Ets binding site is 
highlighted to show its location in the D2 region of DE. Based on the sequence logo, 
mutations were made to alter the binding sequence to prevent the protein from binding.  
 
…..TCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACAC…  
CATTCCTCAGGTC  
Ets1 Binding 
CAGGAATCAGGTC   
D2 E1 
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Runx1 Binding 
Figure 17. Runx-Binding Site Mutation Schematic. The region of DE highlighted is the 
potential Runx binding site. The sequence logo for Runx provided the nucleotides that 
are mutated to prevent binding of the transcription factor.  
 
 
 
CCCGGTGCTCTCTCACATTCCTCAGGTC-TGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCA 
 
 
D2 E1 
TGCACACAGAG TGCGTCTAGCG   
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Figure 18. Sox-Binding Site Mutation Schematic. The potential Sox binding site is 
located in the E1 region of DE as depicted above. The sequence was mutated in 
accordance to the sequence logo for Sox 9.  
Sox 9 Binding 
D2 E1 
TC-TGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACACAGTCAGGGCTCATTTCGGACACACA  
 
ATTGTGTGTG ATCTCGGGTG  
E2 
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TGCATGTCAGGTC  
 
…..TCTCTCACATTCCTCAGGTCTGCACACAGAGCCGCATTGTGTGTGTGTCTTACAGAGCACAC…  
CATTCCTCAGGTC TGCATGTCAGGTC  
D2 E1 
Fli1a  Binding 
Figure 19. Fli-Binding Site Mutation Schematic. After literature review and analysis of 
the data, the original Ets binding site mutation may have provided a better Fli1a binding 
site. More plasmids were created to mutate this potential Fli1a binding site according to 
the sequence logo above.  
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Table 15. Results of injections with DE plasmid containing Ets-binding site mutated. 
M
u
ta
ti
o
n
 E
ts
 Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/24 146 41 28% 103 71% 87 60% 
12/4 51 17 33% 43 84% 35 69% 
12/12 83 33 40% 64 77% 43 52% 
Total 280 91 33% 210 75% 165 59% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Results of Injections with Ets Binding Site Mutated in Plasmid. Zebrafish at 5 dpf 
depicting the EGFP expression pattern of Ets binding site mutated in the DE plasmid. (A) 
Ventral view of craniofacial cartilage. Reflection of fluorescent protein may be visible in the 
eye. (B) Lateral view of zebrafish head. EGFP present in craniofacial cartilage. (C) Lateral 
view of trunk depicting the notochord (5dpf). 
A
A 
B
A 
C
A 
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Table 16. Results of injections with the Runx-binding site mutated in the DE plasmid. 
M
u
ta
ti
o
n
 R
u
n
x
 Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/8 28 7 25% 18 64% 4 14% 
11/6 23 9 39% 4 17% 3 13% 
11/13 82 21 26% 13 16% 7 9% 
12/12 107 60 56% 45 42% 24 22% 
Total 240 97 40% 80 33% 38 16% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Results of Injections with Runx Binding Site Mutated in Plasmid. Zebrafish at 5 
dpf depicting the EGFP expression pattern of Runx binding site mutated in the DE plasmid. 
(A) Ventral view of zebrafish showing EGFP expression in the craniofacial cartilage. (B) 
EGFP present in craniofacial cartilage and ear in lateral view of head. (C) Lateral view of the 
notochord in the trunk region. 
A
A 
B
A 
C 
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Table 17. Results of injections of the DE plasmid with the Sox binding site mutated. 
M
u
ta
ti
o
n
 S
o
x
 Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/24 72 37 51% 46 64% 26 36% 
11/20 44 18 41% 23 52% 9 20% 
12/3 62 25 40% 22 35% 9 15% 
Total 178 80 45% 91 51% 44 25% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C B 
Figure 22. Results of Injections with Sox Binding Site Mutated in Plasmid. Images of 
zebrafish at 5 dpf following injections of the DE plasmid with the Sox binding site mutated. 
(A) Ventral view of craniofacial cartilage. (B) Lateral view of zebrafish head. (C) Lateral view 
of zebrafish head, showing craniofacial cartilage and ear. (D) Lateral view of trunk to show 
notochord. 
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Table 18. Results of injections with Ets and Sox binding sites mutated in DE plasmid. 
M
u
ta
ti
o
n
 E
ts
S
o
x
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/17 98 0 0% 3 3% 2 2% 
11/7 88 15 17% 12 14% 4 5% 
11/21 125 7 6% 25 20% 10 8% 
Total 311 22 7% 40 13% 16 5% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Results of Injections with Ets & Sox Binding Sites Mutated in Plasmid. Low or no 
EGFP expression in zebrafish injected with mutated binding sites of Ets and Sox in DE 
plasmid. (A) Ventral view of craniofacial cartilage at 5 dpf. (B, C) Lateral view of head and 
trunk of zebrafish at 5 dpf. 
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Table 19. Results of Ets and Runx binding sites mutated in DE plasmid injections. 
M
u
ta
ti
o
n
 E
ts
R
u
n
x
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/17 36 3 8% 16 44% 6 17% 
10/31 211 17 8% 33 16% 12 6% 
12/10 10 2 20% 2 20% 1 10% 
12/11 107 12 11% 16 15% 6 6% 
Total 364 34 9% 67 18% 25 7% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Results of Injections with Ets & Runx Binding Sites Mutated in Plasmid. Zebrafish 
at 5 dpf, following injections of DE plasmid with Ets and Runx binding sites mutated. (A) 
Ventral view of craniofacial cartilage. (B) Lateral view of zebrafish head. (C) Lateral view of 
trunk to show notochord. 
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Table 20. Results of Runx and Sox binding sites mutated in the DE plasmid. 
M
u
ta
ti
o
n
 R
u
n
x
S
o
x
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
10/16 9 5 56% 3 33% 1 11% 
10/30 93 30 32% 24 26% 10 11% 
11/21 113 25 22% 35 31% 13 12% 
12/11 78 25 32% 28 36% 8 10% 
Total 293 85 29% 90 31% 32 11% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Results of Injections with Runx & Sox Binding Sites Mutated in Plasmid. Images 
of zebrafish at 5 dpf depicting EGFP expression pattern. (A) Ventral view of craniofacial 
cartilage. (B,C) Lateral view of zebrafish head and trunk, respectively. 
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Table 21. Results of injections with Fli binding site mutated in the DE plasmid. 
M
u
ta
ti
o
n
 F
li
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
4/16 57 28 49% 41 72% 35 61% 
4/17 192 52 27% 118 61% 78 41% 
4/24 78 25 32% 52 67% 34 44% 
4/30 83 42 51% 60 72% 45 54% 
Total 410 147 36% 271 66% 192 47% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Results of Injections with Fli Binding Site Mutated in Plasmid. EGFP expression 
pattern in zebrafish with Fli binding site mutated. (A) Ventral view displaying the EGFP 
expression in the chondrocytes of the craniofacial cartilage. (B) Lateral view of head to 
display expression in the craniofacial cartilage and ear. (C) Lateral view of trunk to visualize 
the notochord. 
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Table 22. Results of injections with mutations in Fli and Runx binding site of DE. 
M
u
ta
ti
o
n
 F
li
R
u
n
x
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
4/10 331 4 1% 16 5% 14 4% 
4/23 186 0 0% 2 1% 15 8% 
4/24 116 1 1% 2 2% 3 3% 
4/30 44 1 2% 2 5% 1 2% 
Total 677 6 1% 22 3% 33 5% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Results of Injections with Fli & Runx Binding Sites Mutated in Plasmid. No 
expression of EGFP in the zebrafish at 5 dpf. (A) Ventral view of craniofacial cartilage. (B) 
Lateral view of zebrafish head to show side view of craniofacial cartilage and ear. (C) Lateral 
view of trunk to show lack of EGFP expression in the notochord. 
B 
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Table 23. Results of DE plasmid with mutations in the Fli and Sox binding sites. 
M
u
ta
ti
o
n
 F
li
S
o
x
 
Date 
Injected 
Fish 
Injected 
Notochord 
Craniofacial 
Cartilage 
Ear 
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
# of GFP 
Positive 
% of GFP 
Positive  
5/2 120 24 20% 65 54% 30 25% 
5/22 48 2 4% 0 0% 0 0% 
Total 168 26 15% 65 39% 30 18% 
 
 
 
 
Figure 28. Results of Injections with Fli & Sox Binding Sites Mutated in Plasmid. Images 
depicting the EGFP expression in zebrafish injected with mutations to the Fli and Sox binding 
sites of the DE plasmid. (A) Ventral view of zebrafish head at 5 dpf displaying craniofacial 
cartilage. (B) Lateral view of zebrafish head to show expression in cartilage and ear. (C) 
Lateral view of trunk to visualize the notochord.  
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Identification of Transcription Factors 
 
The identification of putative transcription factor binding sites was completed 
using bioinformatic analysis, and this focused my research on the Ets, Sox, and Runx 
families of transcription factors. We established the importance of the potential 
transcription factor binding sites based on the decreased reporter expression with mutated 
binding sites.  Next we wanted to establish the exact member of the transcription factor 
family that was bound to the R2-DE region using overexpression analysis. To do this, we 
utilized RT-PCR to clone the zebrafish mRNA homologs for each of the candidate 
transcription factor proteins into in vitro transcription vectors. This allowed us to produce 
mRNA for each transcription factor to be injected into our R2-DE transgenic lines. These 
RNAs were injected into the embryo at the one-cell stage resulting in the early production 
of the transcription factors at a much earlier stage than normal in zebrafish. If the injected 
proteins were indeed bound to the regulatory region, they could prematurely produce the 
reporter protein that would be visible under fluorescence. The embryos of the stable line 
of the R2 and R2-DE zebrafish were injected with the RNA of Fli1a, Sox9a, and Runx3 
simultaneously in order to account for all of the theorized binding sites. As it can take up 
to 2 hours for protein to be made from injected mRNA, we chose to test for reporter 
activity from 6 to 10 hpf, which covers most of gastrulation but before somatogenesis 
when col2a1a expression is first seen by in situ hybridization (Yan et al 1995). When the 
injected embryos were inspected during gastrulation, the animal half of the embryo 
appeared to be fluorescent green. Unfortunately, the uninjected embryos were inspected 
they also appeared to have green fluorescence. There was an inability to distinguish 
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between the injected and uninjected embryos. In order to determine whether the green 
glow in the embryos was from EGFP or auto-fluorescence, an antibody was used to label 
EGFP in the cells. Unfortunately, once again there was no discernable difference between 
the injected and uninjected embryos because the fluorophore was present in both the 
control and injected embryos (Figure 29). Future experiments would be necessary to 
confirm the binding of the candidate transcription factors. 
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Figure 29. Results of Transcription Factor Injections. Images of stable line embryo 
injections with RNA of the transcription factors. Embryos stained with antibody for 
EGFP expression. (A) Wild-type embryos injected with the RNA of Fli1a, Sox9a, and 
Runx3. (B) Stable line of R2 embryos injected with the RNA of Fli1a, Sox9a, and 
Runx3. (C) Stable line of DE embryos injected with the RNA of Fli1a, Sox9a, and 
Runx3. 
A 
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CHAPTER FOUR 
DISCUSSION 
Our experiments have identified the element of the R2 regulatory region that was 
responsible for the transcriptional initiation of col2a1a. The minimization of this region 
has allowed for the identification of specific transcription factor binding sites using 
comparative genomics. Site-directed mutagenesis analysis demonstrated the importance 
of those nucleotide sequences for the activity of R2, but it did not confirm the exact 
member of the transcription factor family binding there. Even though candidate 
transcription factors suspected to bind to these regions based on in silico analysis were 
identified, future experiments would be necessary to confirm our results. Based on the 
conserved nucleotide sequence Fli1a, Runx2b, and Sox9a were believed to bind to the 
R2-DE regulatory element. Future experiments will be to confirm the hypothesis, and 
whether the correct proteins of the transcription factor families were identified. This 
confirmation could be accomplished by chromatin immunoprecipitation assay and or an 
electromobility shift assay in order to confirm an interaction between the DNA sequence 
and transcription factor proteins. This interaction confirmation would provide evidence 
that the transcription factors are sufficient to drive expression of the col2a1a gene in 
zebrafish. These experiments would confirm the DNA binding interactions, which leaves 
the potential for future research to elucidate other protein-protein interactions in this 
complex that are necessary for the regulation of col2a1a. 
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The transcription factor binding sites we have focused on were identified based on 
the cartilage expression present in the R2:D2-E1 region of the col2a1a gene. It was 
interesting that the reporter plasmid with the entire DE region maintained expression in 
the tissues specific to col2a1a expression, but once it was minimized to the D2-E1 unit 
the notochord expression was lost. The loss of the first 30 bp and last 30 bp of the DE 
region have eliminated reporter expression in the notochord, to show that there must have 
been an important binding site for expression in this region. Notochord expression was 
low with the D-E1 region, completely eliminated in the D2-E1 region, but present in 20% 
of the embryos at the D2-E region. For this reason, I hypothesized there was an important 
transcription factor binding site for notochord expression in the E2 region. Once again 
comparative genomics and computer analysis could be used to identify the potential 
transcription factor binding sites, which would demonstrate the sequence could be 
important for notochord expression. Even though we have identified potential 
transcription factor binding sites for cartilage expression, it would be compelling to see 
which transcription factors differ in the notochord expression region. This process could 
identify an enhancer element that is responsible for isolated expression in the notochord, 
which would allow for transcriptional initiation in this specific tissue. This could be 
appealing for many biomedical reasons because of the ability to drive expression of any 
gene in a spatiotemporal manner with this enhancer sequence 
Investigating the transcriptional regulation of zebrafish col2a1a gene entailed 
identifying the components sufficient to drive expression of this gene. The paralogue of 
this gene in zebrafish is col2a1b, which differs in its expression pattern based on in situ 
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hybridization analysis (Dale and Topczewski, 2011), could be another interesting avenue 
to explore. For example, col2a1a is present in the chondrocytes and the perichondrium of 
the pharyngeal arches while col2a1b is restricted to the perichondrium. The experiments 
completed on the regulation of col2a1a identified three potential transcription factor sites, 
but because the homologues have some overlap in tissue specificity their regulatory 
elements could be similar, especially if both paralogues were derived from an earlier gene 
duplication that would have maintained a version of the col2a1a R2 element. Similar to 
the process already completed, the identification of the regulatory element and 
transcription factor binding sites could be achieved with comparative genomics. The 
importance of transcription factor binding sites may again be confirmed with site-directed 
mutagenesis on the reporter plasmids. This research would allow a comparison into how 
the regulation of col2a1a and col2a1b has evolved. 
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